Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis".

Venue / Journal

Antimicrob Agents Chemother

Date

Fri, 09/01/2017 - 12:00

Additional Journal Information

61(9)

Authors

Peloquin CA, Velásquez GE, Lecca L, Calderón RI, Coit J, Milstein M, Osso E, Jimenez J, Tintaya K, Garavito ES, Vasquez DV, Mitnick CD, Davies G.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/28839086